<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Trump Trade: White House releases details on ‘Great Healthcare Plan’

PremiumThe Fly

2d ago

Drugmakers concerned about legal risk with FDA review program, Reuters reports

PremiumThe Fly

2d ago

Sanofi downgraded to Neutral from Buy at UBS

BMY

PremiumThe Fly

2d ago

White House releases details on Trump ‘Great Healthcare Plan’

PremiumThe Fly

3d ago

PremiumThe FlyStreet sees buying opportunity as Disc Medicine slips on FDA review delay

3d ago

LLY

Sanofi prepping higher bid for Ocular Therapeutix, IBD reports

The Fly

Sanofi prepping higher bid for Ocular Therapeutix, IBD reports

3d ago

OCUL

FDA pushes back reviews of several fast-tracked medicines, Reuters reports

The Fly

FDA pushes back reviews of several fast-tracked medicines, Reuters reports

3d ago

LLY

Trump Trade: Trump administration moves to end pharma trade probe

PremiumThe Fly

4d ago

AMD

Trump administration moves to end U.S. pharma trade probe, Endpoints News says

PremiumThe Fly

5d ago

Sanofi CEO says ‘aggressively’ looking for early-stage drug deals

BMY

PremiumThe Fly

6d ago

Sanofi downgraded to Equal Weight from Overweight at Barclays

PremiumThe Fly

12d ago

PremiumThe FlySanofi downgraded to Equal Weight from Overweight at Barclays

12d ago

Kennedy scales back number of vaccines recommended for children, NYT says

The Fly

Kennedy scales back number of vaccines recommended for children, NYT says

13d ago

GSK

Trump Weekly: Furniture tariffs delayed, drugmakers hike prices

Midday Fly By: Nvidia said to see strong H200 demand in China

The Fly

Trump Weekly: Furniture tariffs delayed, drugmakers hike prices

16d ago

PremiumThe Fly

18d ago

CSX

DJT

PremiumThe Fly

Trump Trade: 350 drugs to see price raises despite President’s pressure

18d ago

DIS

PremiumThe Fly

Drugmakers raise U.S. prices on 350 drugs despite Trump pressure, Reuters says

18d ago

GSK

NVS

PremiumThe Fly

Morning Movers: Intel slipping ahead of holiday shortened-session

25d ago

NKE

PremiumThe FlyDynavax jumps 37% to $15.31 after buyout offer from Sanofi

25d ago

DVAX

Sanofi to acquire Dynavax for $15.50 per share in cash, or $2.2B

The Fly

Sanofi to acquire Dynavax for $15.50 per share in cash, or $2.2B

25d ago

DVAX

Sanofi announces European Commission approval of Wayrilz

The Fly

Sanofi announces European Commission approval of Wayrilz

26d ago